Skip to main content

MoneyWorks4Me

Sun Pharma Advanced Research Company informs about press release

26 Nov 2018 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed about submission of the Press Release titled,   ’SPARC announces Top-line Results of Pivotal Bioequivalence Study for Paclitaxel Injection Concentrate for Suspension being released by the company’, which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 42.70
Prime Focus 281.40
Indegene 619.75
Syngene Internatl. 412.75
Knowledge RealtyTrt. 110.00
View more..